Molecular Formula | C27H39ClN2O4 |
Molar Mass | 491.06 |
Melting Point | 142°C (dec.)(lit.) |
Boling Point | 586.1°C at 760 mmHg |
Flash Point | 308.3°C |
Water Solubility | soluble |
Solubility | H2O: >30 mg/mL |
Vapor Presure | 1.01E-13mmHg at 25°C |
Appearance | White to off-white powder |
Color | white |
Storage Condition | 0-6°C |
MDL | MFCD00055208 |
Use | For organic synthesis, pharmaceutical industry; Mainly used for paroxysmal supraventricular tachycardia, but also for angina, hypertension and hypertrophic infarction cardiomyopathy |
Risk Codes | R23/24/25 - Toxic by inhalation, in contact with skin and if swallowed. R36/37/38 - Irritating to eyes, respiratory system and skin. |
Safety Description | S36/37 - Wear suitable protective clothing and gloves. S45 - In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.) S37/39 - Wear suitable gloves and eye/face protection S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. |
UN IDs | UN 2811 6.1/PG 3 |
WGK Germany | 3 |
RTECS | YV8320000 |
FLUKA BRAND F CODES | 8-10 |
Reference Show more | 1. Li Tao, Zhao Xiaoliang, Nie Yinglan, et al. Study on Brain Permeability of Sinomenine and Ligustrazine in CQ Analgesic Compound [J]. Journal of Pharmacy 2019 v.54(12):186-193. 2. Pan Jie, Yang Shuting, Sun Jia, et al. Study on Intestinal Absorption Characteristics of Six Active Components in Hongcao in Normal and Myocardial Ischemia Model Rats [J]. Chinese Pharmacy, 2020(13). 3. Zhang Yu, Ban Yujuan, Wang Zhongyuan, Zhang Li, Tang Lei, Liao Weike. Transport Characteristics of New DPP-4 Inhibitor LGT-6 in Caco-2 Cell Monolayer Model [J]. Chemical reagent, 2021,43(04):434-440. 4. Huang, Yuanjia, et al. "Molecular cloning and characterization of calmodulin-like protein CaLP from the Scleractinian cord Galaxea astreata." Cell Stress and Chaperones 23.6 (2018): 1329-1335.https:// doi.org/10.1007/s12192-018-0907-0 5. [IF = 6.4] Jing Zhao et al. "Natural Nano-Drug Delivery System in Coptidis Rhizoma Extract with Modified Berberine Hydrochloride Pharmacokinetics." Int J Nanomed. 2021; 16: 6297-6311 6. [IF = 5.81] Zhao Jing et al. "Intra-Herb Interactions: primary Metabolites in Coptidis Rhizoma Extract Improved the Pharmacokinetics of Oral Berberine Hydrochloride in Mice." Front Pharmacol. 2021 Jun;0:1426 7. [IF = 4.36] Guanghou Wang et al. "Simultaneous determination of 11 alkaloids in rat plasma by LC-ESI-MS/MS and a pharmacokinetic study after oral administration of total alkaloids extracted from Nauclea officinalis." J Ethnopharmacol 2022 Jan;282:114560 |
This product is (±)-a-[3-[[2-(3, 4-dimethoxyphenyl) ethyl] methylamino] propyl]-3, 4-dimethoxy-isopropylphenylacetonitrile hydrochloride. The content of C27H38N204 • HC1 shall not be less than 98.5% calculated as dry product.
The melting point of this product (General 0612) is 141~145°C.
take l.Og of this product, add water to dissolve 20ml, and then determine it according to law (General rule 0631). The pH value should be 4.5~6.5.
take l.Og of this product, add water 20ml to dissolve, the solution should be clear.
take this product, add mobile phase to dissolve and dilute to make a solution containing about 2.5mg per 1ml as a test solution; Take 1ml for precision measurement and put it in a 100ml measuring flask, dilute to the scale with the mobile phase, shake, and serve as a control solution. According to the chromatographic conditions under the content determination item, 20 u1 of each of the test solution and the control solution are accurately measured and injected into the human liquid chromatograph respectively, and the chromatogram is recorded to 3 times of the retention time of the main component peak. If there are impurity peaks in the chromatogram of the test solution, the sum of each impurity peak area shall not be greater than the main peak area of the control solution (1.0%).
take this product about 0.1g, precision weighing, top empty bottle, precision plus N, N-dimethylformamide 1ml, sealed, as a test solution; Take ethanol, acetone, benzaldehyde, dimethyl sulfoxide, toluene, three gas methane appropriate amount, precision weighing, with N, N-dimethylformamide quantitative dilution made per lml containing ethanol, acetone, benzaldehyde, dimethyl sulfoxide were 0.5mg, toluene 89ug, chloroform 6ug of mixed solution, precision take 1ml, empty bottle, sealed, as a reference solution.
Test as residual solvent assay (General 0861 second method). 6% cyanopropylphenyl-94% dimethylpolysiloxane (or polar similar) as the stationary liquid; The initial temperature is 40°C, maintained for 3 minutes, and the temperature is raised to 100°C at a rate of 3°C per minute, the temperature was then increased to 240°C at a rate of 30°C per minute for 3 minutes; The inlet temperature was 150°C; The detector temperature was 280°C; The headspace bottle equilibrium temperature was 90°C, and the equilibrium time was 30 minutes. Take the reference solution into the headspace, the separation degree between the peaks of each component shall meet the requirements. Then the sample solution and the reference solution were injected with headspace, and the chromatogram was recorded. According to the external standard method to calculate the peak area, the residual amount of benzaldehyde shall not exceed 0.5%, ethanol, acetone, dimethyl sulfoxide, toluene and chloroform residues shall be in accordance with the provisions.
take this product, dry to constant weight at 105°C, weight loss shall not exceed 0.5% (General rule 0831).
l.Og of this product shall be taken and inspected according to law (General rule 0841), and the remaining residue shall not exceed.
The residue left under the item of burning and flooding shall be inspected according to law (general law 0821, Law II) and shall not contain more than 10 parts per million of heavy metals.
measured by high performance liquid chromatography (General 0512).
silica gel was bonded with octa-alkyl silane as filler; Acetic acid-sodium acetate solution (sodium acetate 1.36g, add appropriate amount of water, shake to dissolve, add 33ml of glacial acetic acid, dilute to 1000ml with water, shake well)-methanol-triethylamine (55:45:1) as mobile phase; Column temperature 40°C; Detection wavelength was 278Mn. The theoretical plate number is not less than 2000 calculated as the verapamil peak.
take an appropriate amount of this product, precision weighing, plus mobile phase dissolution and quantitative dilution to make a solution containing about 0.25mg per lml, precision measurement of 20 u1, injection of human liquid chromatography, record the chromatogram; another Verapamil hydrochloride reference substance, precision weighing, the same method for determination. According to the external standard method to calculate the peak area, that is.
calcium channel blockers.
sealed storage.
This product contains Verapamil hydrochloride (C27H38N204 • HCI) should be 90.0% ~ 110.0% of the label amount.
This product is sugar-coated tablets, White after removing the coating.
Take 20 tablets of this product, remove the coating, precision weighing, fine grinding, precision weighing an appropriate amount (about 0.125g equivalent to Verapamil hydrochloride), put it in a 50ml measuring flask, and add an appropriate amount of mobile phase, shake to dissolve Verapamil hydrochloride and dilute to the scale, shake well, filter, Take 5ml of continuous filtrate accurately, put it in 50ml measuring flask, dilute to the scale with mobile phase, shake well, as a test solution. According to the method of Verapamil hydrochloride content determination, according to the external standard method to calculate the peak area, that is.
Same as Verapamil hydrochloride.
40mg
sealed preservation
This product is a sterile aqueous solution of Verapamil hydrochloride. Containing Verapamil hydrochloride (C27H38N204 • HCl) shall be between 93.0% and 107.0% of the labeled amount.
This product is a clear colorless liquid.
after the product was dried by evaporation on a water bath, the same results were shown in the tests (1), (2) and (4) under the item of residual submerged irradiation of Verapamil hydrochloride.
take an appropriate amount of this product (about 12.5mg equivalent to Verapamil hydrochloride), put it in a 50ml measuring flask, dilute it to the scale with mobile phase, and shake it well to serve as a test solution. According to the method of Verapamil hydrochloride content determination, according to the external standard method to calculate the peak area, that is.
Same as Verapamil hydrochloride.
2ml:5mg
light shielding, closed storage.
This product contains Verapamil hydrochloride (C27H38N204 • HCl) should be 93.0% ~ 107.0% of label amount.
This product is white-like tablets.
Take 20 tablets of this product, precision weighing, fine grinding, precision weighing an appropriate amount (about 25mg equivalent to Verapamil hydrochloride), put it in a 100ml measuring flask, add an appropriate amount of mobile phase, ultrasonic dissolution of Verapamil hydrochloride and diluted to scale, shake, filter, take the filtrate as a test solution. According to the method of Verapamil hydrochloride content determination, according to the external standard method to calculate the peak area, that is.
Same as Verapamil hydrochloride.
120mg
sealed storage.